XJPX
7745
Market cap501mUSD
Oct 09, Last price
2,976.00JPY
1D
2.90%
1Q
1.85%
Jan 2017
535.90%
IPO
156.55%
Name
A&D Holon Holdings Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
A&D HOLON Holdings Company Limited, founded in 1977 and headquartered in Tokyo, Japan, specializes in delivering a broad spectrum of measurement and analysis technologies. Its extensive product catalog encompasses sophisticated systems for measurement, control, and simulation, alongside analytical instruments such as FFT, sound, and vibration analyzers. The company also manufactures digital ultrasonic devices for detecting flaws and measuring thickness, as well as machinery for material testing, and A/D D/A converters crucial for semiconductor fabrication. Moreover, A&D HOLON provides a wide array of weighing equipment, including precision electronic balances, digital platform scales, industrial weighing systems, indicators, controllers, and advanced data processing systems for both weighing and general measurement. For the medical and home health markets, their offerings include digital blood pressure monitors for clinical and personal use, a variety of scales designed for healthcare settings, consumer digital scales, and ultrasonic nebulizers. The company's precision technologies further extend to photomask CD-SEM and defect review SEM products, along with specialized tools for roller mold measurement.
Key people
Ko Cho
Executive Vice President, President of Subsidiary, Director · since 2022
Koji Takahashi
Managing Executive Officer, Director · since 2025
Yasunobu Morishima
Executive President, Representative Director · since 2022
Yasuhiro Daisho
Independent Director · since 2018
Kunio Kamide
Independent Director · since 2025
Kazuko Rudy
Independent Director · since 2023
Fumiaki Shigemitsu
Independent Director · since 2022
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||